Skip to main content
Fig. 5 | Translational Neurodegeneration

Fig. 5

From: Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson’s disease

Fig. 5

Verification of screened miRNA by qRT-PCR assay. a–g Expressions of hsa-miR-374a-5p (a), hsa-miR-374b-5p (b), hsa-miR-199a-3p (c), hsa-miR-195-5p (d), hsa-miR-28-5p (e), hsa-miR-22-5p (f), and hsa-miR-151a-5p (g) in stages II–IV. Data were analyzed by one-way ANOVA with Dunnett’s multiple comparisons test (mean ± SD; n = 40; *P < 0.05, **P < 0.01, ****P < 0.0001)

Back to article page

Translational Neurodegeneration

ISSN: 2047-9158

Contact us